E2F-4 inhibitors belong to a class of compounds designed to selectively target and inhibit the function of E2F-4, a transcription factor that plays a significant role in cell cycle regulation and proliferation. E2F-4 is a member of the E2F family of transcription factors, which are involved in controlling the expression of genes required for cell cycle progression, DNA replication, and cellular proliferation. E2F-4 functions in association with other proteins to mediate the transition of cells from the G1 phase to the S phase of the cell cycle.
Inhibiting E2F-4 aims to disrupt its transcriptional activity and subsequent regulation of cell cycle-related genes. By interfering with E2F-4's role in controlling the cell cycle, these inhibitors can modulate cellular proliferation and division. The development of E2F-4 inhibitors provides researchers with a tool to investigate the specific functions of E2F-4 and its contributions to normal cell cycle progression and disease states such as cancer. Understanding the molecular mechanisms underlying E2F-4's actions can shed light on the intricate control of cell division and proliferation and may uncover avenues for targeted interventions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $116.00 $230.00 | 12 | |
Gossypol is a natural compound that might interfere with E2F-4 and cell cycle progression through various mechanisms, including apoptosis induction. | ||||||